Dextranomer
 | |
| Clinical data | |
|---|---|
| Trade names | Debrisan |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Topical |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem SID | |
| ChemSpider |
|
| ECHA InfoCard | 100.128.106 |
  (what is this?) (verify) | |
Dextranomer (trade name Debrisan) is a cicatrizant used in dressings for wound healing,[1] and in pharmaceutical products to treat fecal incontinence.[2] It consists of dextran polymer chains cross-linked into a three-dimensional network.[3]
Solesta
Solesta is the marketed brand name of a system of injections of dextranomer in stabilized sodium hyaluronate for use in fecal incontinence (FI).[4] This preparation is a biocompatible gel, for use as a perianal injectable bulking agent. The system is intended to be injected in the submucosal layer of the proximal anal canal (i.e. above the level of the dentate line).
References
- ^ Parulkar BG, Sobti MK, Pardanani DS (1985). "Dextranomer dressing in the treatment of infected wounds and cutaneous ulcers". J Postgrad Med. 31 (1): 28–33.
- ^ Solesta Gel Approved for Fecal Incontinence
- ^ Solesta Package Insert
- ^ Hoy, SM (Aug 20, 2012). "Dextranomer in stabilized sodium hyaluronate (Solesta): in adults with faecal incontinence". Drugs. 72 (12): 1671–8. doi:10.2165/11209030-000000000-00000. PMID 22845415.
External links
- dextranomer at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |